Just over two weeks ago, we were delighted to hear at Myeloma Australia the changes to the pharmaceutical benefit scheme (PBS) listing for Pomalidomide (Pomalyst®). Whilst the notation was slight, the...
Jun
2018
15
Running blog “Let the training commence” “White rabbits” “pinch, punch first day of the month” also day one of my training for “Team Myeloma” City to Surf 2018! I have entered this event several times...
May
2018
25
Myeloma Australia is committed to keeping the Australian myeloma community informed about any new treatment submissions to be considered by the Pharmaceutical Benefits Advisory Committee (PBAC). The P...
Apr
2018
20
There is much activity at this time in the fundraising space of Myeloma Australia. Our first major fundraising event for the year was our flagship Business of Winning Luncheon at the MCG. This was a g...
0
Feb
2018
23
A team from Myeloma Australia visited Atlanta USA in December 2017 as invited guests of the International Myeloma Foundation (IMF). This gave us the opportunity to attend the world’s biggest haematolo...
Dec
2017
22
The PBAC met in November this year to review the most recent applications for new drugs or amendments to the prescribing rules for existing drugs. Four myeloma drugs were reviewed during this meeting....